You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Evercore ISI on Thursday upgraded PerkinElmer's shares to Outperform from a prior In Line rating, but the investment bank downgraded Hologic's stock to In Line from an Outperform rating.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.